IPO Update: Pasithea Therapeutics Readies $17 Million IPO Plan
sanjeri/E+ via Getty Images
Quick Take
Pasithea Therapeutics (KTTA) intends to raise $17 million from the sale of its common stock in an IPO, according to an amended registration statement.
The company is developing psychiatric drugs to treat the underlying…
